Achaogen Inc. | Key People and Executives

Kenneth J. Hillan
President & Director
Blake Wise
Chief Executive Officer & Director
Bryan E. Roberts
Chairman
Karen Bernstein
Independent Director
Halley E. Gilbert
Independent Director
Michael Fischbach
Independent Director
Gregory Stea
Independent Director
Kent E. Lieginger
Independent Director
John W. Smither
Independent Director
John C. Doyle
Independent Director
Kenneth J. Hillan
President & Director
Blake Wise
Chief Executive Officer & Director
Liz Bhatt
Chief Operating & Business Officer
Tobin Schilke
Chief Financial Officer
Lee Swem
Chief Scientific Officer
Gary H. Loeb
Chief Compliance Officer & General Counsel
Janet Dorling
Chief Commercial Officer
Zeryn Sarpangal
Chief of Staff
Bryan E. Roberts
Chairman
Karen Bernstein
Independent Director
Halley E. Gilbert
Independent Director
Michael Fischbach
Independent Director
Gregory Stea
Independent Director
Kent E. Lieginger
Independent Director
John W. Smither
Independent Director
John C. Doyle
Independent Director

About Achaogen

View Profile
Address
1 Tower Place
South San Francisco California 94080
United States
Employees -
Website http://www.achaogen.com
Updated 09/14/2018
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E.